Tempest Therapeutics Statistics Share Statistics Tempest Therapeutics has 4.44M
shares outstanding. The number of shares has increased by null%
in one year.
Shares Outstanding 4.44M Shares Change (YoY) n/a Shares Change (QoQ) n/a Owned by Institutions (%) 5.55% Shares Floating n/a Failed to Deliver (FTD) Shares 276 FTD / Avg. Volume 0.21%
Short Selling Information The latest short interest is 185.36K, so 4.17% of the outstanding
shares have been sold short.
Short Interest 185.36K Short % of Shares Out 4.17% Short % of Float 4.18% Short Ratio (days to cover) 1.99
Valuation Ratios The PE ratio is -7.24 and the forward
PE ratio is -0.69.
Tempest Therapeutics's PEG ratio is
0.34.
PE Ratio -7.24 Forward PE -0.69 PS Ratio 0 Forward PS 2.7 PB Ratio 15.83 P/FCF Ratio -9.05 PEG Ratio 0.34
Financial Ratio History Enterprise Valuation Currently the Enterprise Value (EV) is not available for Tempest Therapeutics.
EV / Sales n/a EV / EBITDA n/a EV / EBIT n/a EV / FCF n/a
Financial Position The company has a current ratio of 2.21,
with a Debt / Equity ratio of 0.8.
Current Ratio 2.21 Quick Ratio 2.21 Debt / Equity 0.8 Debt / EBITDA -0.38 Debt / FCF -0.46 Interest Coverage -31.93
Financial Efficiency Return on Equity is n/a and Return on Invested Capital is n/a.
Return on Equity n/a Return on Assets n/a Return on Invested Capital n/a Revenue Per Employee n/a Profits Per Employee $-1.74M Employee Count 24 Asset Turnover 0 Inventory Turnover n/a
Taxes Income Tax n/a Effective Tax Rate 0%
Stock Price Statistics The stock price has increased by -34.8% in the
last 52 weeks. The beta is -2.29, so Tempest Therapeutics's
price volatility has been lower than the market average.
Beta -2.29 52-Week Price Change -34.8% 50-Day Moving Average 8.21 200-Day Moving Average 9.27 Relative Strength Index (RSI) 62.89 Average Volume (20 Days) 134,609
Income Statement
Revenue n/a Gross Profit -389K Operating Income -42.03M Net Income -41.84M EBITDA -40.14M EBIT -40.53M Earnings Per Share (EPS) -1.5
Full Income Statement Balance Sheet The company has 30.27M in cash and 15.37M in
debt, giving a net cash position of 14.9M.
Cash & Cash Equivalents 30.27M Total Debt 15.37M Net Cash 14.9M Retained Earnings -207.11M Total Assets 24.48M Working Capital 7.96M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was -33.03M
and capital expenditures -435K, giving a free cash flow of -33.46M.
Operating Cash Flow -33.03M Capital Expenditures -435K Free Cash Flow -33.46M FCF Per Share -1.2
Full Cash Flow Statement Margins
Gross Margin n/a Operating Margin n/a Pretax Margin n/a Profit Margin n/a EBITDA Margin n/a EBIT Margin n/a FCF Margin n/a
Dividends & Yields TPST does not appear to pay any dividends at this time.
Dividend Per Share n/a Dividend Yield n/a Dividend Growth (YoY) n/a Payout Ratio n/a Earnings Yield n/a FCF Yield n/a
Dividend Details Analyst Forecast The average price target for TPST is $16,
which is 47.5% higher than the current price. The consensus rating is "Hold".
Price Target $16 Price Target Difference 47.5% Analyst Consensus Hold Analyst Count 3
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value n/a Lynch Upside n/a Graham Number n/a Graham Upside n/a
Stock Splits The last stock split was on Apr 9, 2025. It was a
backward
split with a ratio of 1:13.
Last Split Date Apr 9, 2025 Split Type backward Split Ratio 1:13
Scores Altman Z-Score -16.55 Piotroski F-Score 3
